Skip to main content

Table 3 Comparison of safety evaluation between polymyxin B and colistin sulfate groups

From: Comparative study of polymyxin B and colistin sulfate in the treatment of severe comorbid patients infected with CR-GNB

 

Polymyxin B (N = 68)

Colistin sulfate (N = 36)

P.value

Hepatotoxicity

 Total bilirubin increased

2 (3.9%),n = 51

2 (6.1%),n = 33

0.644

 Alanine aminotransferase increased

5 (10.0%),n = 50

4 (13.3%),n = 30

0.722

 Aspartate aminotransferase increased

5 (10.9%),n = 46

9 (28.1%),n = 32

0.051

Nephrotoxicity

 Abnormal serum creatinine

6 (14.6%),n = 41

3 (15.0%),n = 20

1.000

Hematotoxicity

 Platelet decline

10 (21.2%),n = 47

4 (13.3%),n = 30

0.378